InvestorsHub Logo
Followers 617
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: FarmaZutical post# 372

Tuesday, 09/06/2016 5:08:21 PM

Tuesday, September 06, 2016 5:08:21 PM

Post# of 733
Thanks for the interesting link... and, I'm especially thankful for google translate! ;)

I don't do well beyond very basic conversational German.







In Reply to 'FarmaZutical'
German analysis of Clinuvel's potential. Very well written and levelheaded. I still think, though, that the author sets the number of EPP patients far too low. I would also adjust the number of Vitiligo patient to reflect the 2-5 % prevalence in the US and the fact that Scenesse will target FP4-5. Still, the number of potential patients is a lot higher than what the author assumes. But I like his conservative approach and comprehensive analysis.

http://minussinus.de/clinuvel-unterbewertetes-pharmaunternehmen-startet-markteinfuehrung/




To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.